OrthoStreams is ONLY available by subscription—join the other 7,103 subscribers for exclusive daily articles, newsletters, and deep-dive reports. Loyal OrthoStreams […]
For decades, scoliosis bracing has looked the same. Like this Boston Brace image below. Hard plastic prisons. Movement, breathing and
According to industry data, only about 10-15% of medical device startups achieve significant market traction or an exit event like
A compelling trend emerged in our ortho industry: companies are staying private far longer than they used to. IPOs have
It’s early, but very promising. Abanza’s WasherCap™ devices are poise to revolutionize soft-tissue graft fixation with bone-independent design, up to
Our industry has created fortunes for those who navigate it with precision. From trailblazing entrepreneurs like Dane Miller or Maurice
Orthopedic companies thrive by creating moats—strategic advantages that protect their market position and fuel growth. Like the moats around medieval
WARNING: This article might sting for those in Big Ortho chugging the “Enabling Technology” Kool-Aid. Background The term “Enabling Technology”
You’ve likely seen virga—rain that falls but never hits the ground. It’s a striking sight, especially at sunrise or sunset,
Why don’t other orthopedic startups prioritize “simplicity first” as a foundational principle? In a recent discussion with the private BoneChat
Orthopedic startups chase FDA clearance like it’s the ultimate prize. Years of grinding through R&D, clinical trials, and regulatory hoops
Discover why VC scouts are vital for orthopedic medtech startups. Learn how scouts with insights like Tiger unlock funding and
MY01’s sensor-based tool monitors limb perfusion and pressure in real-time, enabling early detection of acute injuries like compartment syndrome to
The presence of sales reps in the OR has become a polarizing topic. So let’s explore deeper. Why are sales
I just read an article after Medtronic’s earnings call – Why Medtronic plans to spin out its diabetes business. Quick
Keith Griesbaum reached out to me because he is about to start a Podcast with Stefan Vojt about Ortho Sales.
A recent conversation sparked a thought-provoking question: Is a significant portion of this market—perhaps as much as 80%—effectively “locked up”?
How to Become Wealthy Working in the Orthopedic IndustryDiscover how to build wealth in orthopedics by choosing emerging niches, collaborating
Let’s cut through the noise. J&J’s new VELYS Spine system, hyped in BoneZone’s “VELYS Spine Shows What’s Next in Enabling
“The Big Orthos are hunting for early stage orthos with cameras, not guns.” I have conversations with startup leaders each week
In sports medicine, the enthesis—a critical tendon-bone junction—poses a costly challenge, with high failure rates demanding innovative solutions. In the
Learn how the “Onion Theory of Risk” helps ortho startups peel away uncertainties, secure funding, and build investor confidence. Today
Wow, Anika’s stock tanked post-Q1 2025 earnings due to a 10% revenue drop, lower OEM pricing, manufacturing issues, and reduced
Learn to dominate niches in orthopedics using the Hedgehog Strategy: focus on a unique strength, solve specific problems, and build
Discover how a Swiss startup new to the US is revolutionizing orthopedic trauma care with streamlined, effective solutions tailored for
Globus Medical Inc.’s stock plummeted 22.96% after its Q1 2025 earnings call, driven by a disappointing revenue performance, lowered EPS
You’ll learn to connect emotionally, pitch persuasively, and stand out to close more orthopedic sales effectively. Invisible tattoo on your
The orthopedic startup scene is a thrilling ride—new ideas, eager surgeon investors, and the buzz of early sales can make
In the ortho startup world, the journey from innovation to success often follows a predictable arc—one that’s beautifully illustrated by
Today, I am sharing 30 lessons for emerging orthopedic companies. I love to help my friends in the smaller ortho
The orthopedic industry is a dynamic landscape where innovation, strategy, and execution determine which companies thrive and which languish. While
Labramend is a stealth startup in orthopedics with a product design that we need to turn into an inflatable balloon.
Learn the essential strategies orthopedic startups need to transform cutting-edge technology into market success, avoiding the “Field of Dreams” trap.
I hunt for game-changers—technologies that don’t just nudge the needle but rewrite the rules. VISIE is one of those rare
Key Points Research suggests fewer ETO sterilization suppliers in the US due to stricter regulations and health concerns. It seems
Tiger’s world’s is built on helping small orthopedic companies and entrepreneurs thrive, and there is a deliberate ecosystem to make
The spine industry is buzzing with futuristic ideas—AI-crafted implants, robotic precision, and augmented reality guiding surgeons’ hands. These concepts, spotlighted
At what point did selling orthopedic products stop being about clinical value and patient outcomes—transforming entirely into a game of
Sharing with the Orthopedics world my newly created AI clone trained on thousands of orthopedic articles and conversations. Whether you
The Problem – Vague Silence. Orthopedic startups struggle to secure funding, facing a wall of silence from VCs. Pitch after
A Tale of Frozen Ambition Jim, a marketing lead at an orthopedic startup, called me. He had a vision: a
Simple. Bring on board people and consultants from large established companies—places with flawless organization, top-notch systems, and airtight processes. Done.
Learn the 4 keys to running cost-effective trials with lean data, scalable designs, smart tech, and expert partnerships. Early-stage orthopedic
Launching an ortho startup? Focus on three essentials in Year Zero: team, product, and customers. Here’s the breakdown. 1. Obsess
Key Points Research suggests Trump’s tariffs are likely impacting US-based orthopedic medical device companies, increasing costs and disrupting supply chains.
But wait there’s more. GLP-1s continue to bring miracles. The new study, “Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel
The Orthopedic cartel like Stryker, Zimmer Biomet, and Johnson & Johnson are players in a high-stakes Game Theory showdown. Stryker’s
GLP-1 drugs (e.g., Ozempic, Mounjaro), primarily used for type 2 diabetes and weight loss, can have several implications for potential
Sharing a quick example from S. Korea that has a small US office in Irvine. CG MedTech is a South
Our industry is shifting fast, and some old ways are losing ground. I am tracking a few changes to keep
